Indoco Remedies Limited

Aditi Milind Panandikar

Ranjeet Nair

Kavita Inamdar

Sundeep Bambolkar

Mangesh Narayan Rajadhyaksha

Sapna Ramesh

Sandip Kacharu Deshmukh

Pradnya M Bagde

Nasir Shaikh

Palangat Vayalileveetil Ramesan

Nilesh Balkrishna Shrigadi

Somnath Ambadas Khabale

Amol Burkul

Srinivasan Subramanian Kuduva

Nilima Sheth

Pradnya Bagde

The present invention DISCLOSES a novel process for preparing sodium glucose transporters 2 (SGLT2) inhibitor compounds of Formula IX.  

Process for the preparation of SGLT inhibitor compounds

The present invention relates to a process for manufacturing sterile Brinzolamide Ophthalmic Suspension. Specifically, the present invention relates to a process for manufacturing sterile ophthalmic suspension comprising Brinzolamide sterilized by Dry Heat Sterilization and pharmaceutical suspension obtained by using the said sterilized Brinzolamide. The present invention also relates to a process of manufacturing sterile ophthalmic suspension comprising combination of Brinzolamide sterilized by Dry Heat Sterilization and beta blocker.

Process for manufacturing sterile brinzolamide ophthalmic suspension

The present invention relates to a novel pharmaceutical composition of Linezolid. The present invention relates to a novel pharmaceutical composition comprising Linezolid Form III along with pharmaceutically acceptable excipients and a process to prepare the said composition. The present invention relates to an oral dosage forms for the treatment of severe infections caused by Gram-positive bacteria.

Pharmaceutical composition of linezolid

The present invention discloses novel process for the preparation of (2R)-2-acetamido-N- benzyl-3-methoxypropanamide of Formula I involving novel intermediates of Formula-XIX and Formula-XX. 

Process for preparation of lacosamide and some N-benzyl-propanamide intermediate derivatives

Disclosed herein is an improved process for the preparation of 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol of Formula-I and its pharmaceutically acceptable salt which comprises the reaction of (S)-1-(dimethylamino)-2-methylpentan-3-one of formula VIII with 3-bromo anisole of formula II under Grignard conditions to get the compound (2S,3R)-1-(dimethylamino)-3-(3-methoxyphenyl)-2-methyl pentan-3-ol of formula V followed by activation of the &#x2014;OH group of the formula V to convert into sulfonate esters of formula IX, which are on reductive deoxygenation to yield (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentan-1-amine of formula VII and demethylation of formula VII to obtain the compound 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol of Formula-1.

Process for the preparation of tapentadol

Growing community of inventors

Mumbai, India

Aditi Milind Panandikar